Cancer Cachexia Market Size

  • Report ID: 5372
  • Published Date: Oct 09, 2024
  • Report Format: PDF, PPT

Cancer Cachexia Market Size

Cancer Cachexia Market size was over USD 2.49 billion in 2024 and is projected to cross USD 4.58 billion by the end of 2037, growing at more than 4.8% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of cancer cachexia is estimated at USD 2.59 billion.. Over the course of the projection period, which runs from 2024 to 2036, the growing geriatric population is anticipated to support market expansion. The percentage of the population that is 60 years of age or older is rising. There were one billion individuals sixty years of age or older in the world in 2019. By 2030, there will be 1.4 billion, and by 2050, there will be 2.1 billion. Elderly people's weakened immune systems make them more prone to diseases, which is predicted to accelerate the market's growth pace.

In addition to these, the market for cancer cachexia will also grow as a result of increased awareness-raising campaigns by public and private institutions. The market for cancer cachexia will also grow as a result of developments in the treatment of cancer cachexia and sedentary lifestyles.


Cancer Cachexia Market
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 5372
  • Published Date: Oct 09, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of cancer cachexia is estimated at USD 2.59 billion.

The cancer cachexia market size was over USD 2.49 billion in 2024 and is projected to cross USD 4.58 billion by the end of 2037, growing at more than 4.8% CAGR during the forecast period i.e., between 2025-2037. Increasing prevalence of chronic diseases, drug launches, research and development will drive the market growth.

North America industry is anticipated to hold largest revenue share 30% by 2037, impelled by rising health expenditure in the region

The major players in the market are Veru, Inc, Eli Lilly and company, Bristol-Myers Squibb Company, Mylan N.V., ANI Pharmaceuticals, Novartis AG, Hikma Pharmaceuticals Plc., Sun pharmaceutical Industries Ltd., and others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample